Clinical Trial Update: Ga-68-PSMA-11 in Men With Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update for Ga-68-PSMA-11 in prostate cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Adenocarcinoma
• Prostate Cancer

Drugs mentioned

• Ga-68 PSMA-11 (Gallium-68 labeled PSMA-11 radiopharmaceutical imaging agent)

Snippet

Sponsor: Timothy Hoffman | Conditions: Prostate Cancer, Prostate Adenocarcinoma | Phase 3 | Status: TERMINATED